Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Acipimox (K-9321) is a niacin derivative and nicotinic acid analog with activity as a hypolipidemic agent. Acipimox has special application for the treatment of hyperlipidemia in non-insulin-dependent diabetic patients.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 30.00 | |
25 mg | In stock | $ 47.00 | |
50 mg | In stock | $ 65.00 | |
100 mg | In stock | $ 97.00 | |
200 mg | In stock | $ 143.00 | |
500 mg | In stock | $ 238.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 39.00 |
Description | Acipimox (K-9321) is a niacin derivative and nicotinic acid analog with activity as a hypolipidemic agent. Acipimox has special application for the treatment of hyperlipidemia in non-insulin-dependent diabetic patients. |
Synonyms | Olbemox, K-9321 |
Molecular Weight | 154.12 |
Formula | C6H6N2O3 |
CAS No. | 51037-30-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 15.4 mg/mL (100 mM)
H2O: 15.4 mg/mL (100 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Acipimox 51037-30-0 Others nicotinic acid Olbemox K 9321 K9321 K-9321 derivative antilipolytic lipolysis analogue inhibit autonomic tone Inhibitor diabetes inhibitor